Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.34 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.31 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.31 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.31 |
| ▸ | MGLL | Q99685 | 1/20 | 0.31 |
| ▸ | CASP3 | P42574 | 1/20 | 0.31 |
| ▸ | CASP7 | P55210 | 1/20 | 0.31 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2922550 | 1.00 | FAAH (0.34) | FAAHCHRNB2CHRNA7CHRNA4MGLL | |
| SCHEMBL786721 | 1.00 | FAAH (0.34) | FAAHCHRNB2CHRNA7CHRNA4MGLL | |
| SCHEMBL633078 | 0.93 | GBA1 (0.32) | KMT2A | |
| SCHEMBL369965 | 0.86 | GBA1 (0.43) | FAAHMGLL | |
| SCHEMBL5303207 | 0.86 | GBA1 (0.43) | FAAHMGLL | |
| SCHEMBL4282749 | 0.86 | GBA1 (0.43) | FAAHMGLL | |
| SCHEMBL2056924 | 0.86 | — | — | |
| SCHEMBL7355166 | 0.78 | SMN1; SMN2 (0.32) | KMT2A | |
| Water SCHEMBL28388741 | 0.77 | ALDH1A1 (0.33) | KMT2A | |
| SCHEMBL7898121 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4616845-A2 | SKIN PROTECTANT FILM INCLUDING SKIN HEALTH INGREDIENTS | Hollister Incorporated (US) | 2025-09-17 | — | — | EP | claimed |
| US-20240277905-A1 | SKIN PROTECTANT FILM INCLUDING SKIN HEALTH INGREDIENTS | HOLLISTER INCORPORATED | 2024-08-22 | — | — | US | claimed |
| US-11986574-B2 | Skin protectant film including skin health ingredients | HOLLISTER INCORPORATED (US) | 2024-05-21 | — | — | US | claimed |
| US-6582683-B2 | Of a hydrophilic polymer emulsion and a hydrophobic polymer emulsion; use to protect skin from irritants, chemical or pathogenic | SKINVISIBLE PHARMACEUTICALS, INC. | 2003-06-24 | — | — | US | claimed |
| EP-0838498-B1 | CARBOXYLATED POLYMER COMPOSITION | SUMITOMO SEIKA CHEMICALS (JP) | 2002-11-13 | — | — | EP | claimed |
| US-20020051797-A1 | DERMAL BARRIER COMPOSITION | SKINVISIBLE PHARMACEUTICALS, INC. | 2002-05-02 | — | — | US | claimed |
| US-6261690-B1 | DISPERSION IN HIGH BOILING HEAT EXCHANGE MEDIA | AVENTIS RESEARCH & TECHNOLOGY GMBH & CO. KG (DE) | 2001-07-17 | — | — | US | claimed |
| EP-4616845-A2 | SKIN PROTECTANT FILM INCLUDING SKIN HEALTH INGREDIENTS | Hollister Incorporated (US) | 2025-09-17 | — | — | EP | disclosed |
| CN-120131465-A | Oily eyebrow and eye line raincoat capable of prolonging makeup time | 浙江睛姿化妆品有限公司 | 2025-06-13 | — | — | CN | disclosed |
| US-12195632-B2 | Oil-based inkjet ink | RISO KAGAKU CORPORATION (JP) | 2025-01-14 | — | — | US | disclosed |
| US-20240277905-A1 | SKIN PROTECTANT FILM INCLUDING SKIN HEALTH INGREDIENTS | HOLLISTER INCORPORATED | 2024-08-22 | — | — | US | disclosed |
| US-11986574-B2 | Skin protectant film including skin health ingredients | HOLLISTER INCORPORATED (US) | 2024-05-21 | — | — | US | disclosed |
| WO-2024059862-A2 | FIBROIN PEPTIDES AND PROTEIN FRAGMENTS COMPOSITIONS | EVOLVED BY NATURE, INC. (US) | 2024-03-21 | — | — | WO | disclosed |
| WO-2004073644-A2 | WATER-SOLUBLE SILK PROTEINS IN COMPOSITIONS FOR SKIN CARE, HAIR CARE OR HAIR COLORING | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2004-09-02 | — | — | WO | disclosed |
| US-20040170590-A1 | Water-soluble silk proteins in compositions for skin care, hair care or hair coloring | E. I. DU PONT DE NEMOURS AND COMPANY | 2004-09-02 | — | — | US | disclosed |
| US-6582683-B2 | Of a hydrophilic polymer emulsion and a hydrophobic polymer emulsion; use to protect skin from irritants, chemical or pathogenic | SKINVISIBLE PHARMACEUTICALS, INC. | 2003-06-24 | — | — | US | disclosed |
| US-6497889-B2 | CONTAINING HYDROXYPROLINE COMPOUND | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2002-12-24 | — | — | US | disclosed |
| US-20020051797-A1 | DERMAL BARRIER COMPOSITION | SKINVISIBLE PHARMACEUTICALS, INC. | 2002-05-02 | — | — | US | disclosed |
| US-20020009472-A1 | Cosmetics | KYOWA HAKKO BIO CO., LTD. (JP) | 2002-01-24 | — | — | US | disclosed |
| EP-1166767-A2 | Skin care product containing hydroxyproline or N-acylated hydroxyproline derivatives | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2002-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020051797-A1 | DERMAL BARRIER COMPOSITION | CUTA, DSG1, POLR1C | FAAH 94/4885CHRNB2 4221/4885CHRNA7 3941/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.